{"ticker": {"uuid": "2bb665ea-f020-4920-a400-e76e9382824a", "symbol": "AXGN", "name": "Axogen Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "(AXGN) and the Role of Price-Sensitive Allocations", "summary": "Axogen Inc. (NASDAQ: AXGN) is showing weak near and mid-term sentiment, but a strong long", "url": "https://news.stocktradersdaily.com/news_release/24/AXGN_and_the_Role_of_Price-Sensitive_Allocations_071726075002_1784289002.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-17T07:39:43", "published_display": "17 Jul 2026 07:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026", "summary": "Axogen, Inc. announced that it will release its second quarter 2026 financial results on Wednesday, July 29, 2026. Following the release, Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET. The company specializes in surgical solutions", "url": "https://sg.finance.yahoo.com/news/axogen-inc-report-second-quarter-110000045.html", "source_name": "Market source", "published_at": "2026-07-15T14:39:43", "published_display": "15 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen schedules investor webcast after July 29 results", "summary": "Axogen (Nasdaq: AXGN) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, followed by a conference call and webcast hosted by management at 8:00 a.m. ET. Investors can access the call via phone or webcast on the Axogen Investors webpag", "url": "https://www.stocktitan.net/news/AXGN/axogen-inc-to-report-second-quarter-2026-financial-results-on-july-lfanadem2e9o.html", "source_name": "Stock Titan", "published_at": "2026-07-15T10:45:07", "published_display": "15 Jul 2026 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Axogen (AXGN) As Russell Index Removal Tests A Narrative Of Undervaluation", "summary": "Axogen (AXGN) has been removed from several Russell indexes, potentially reshaping trading patterns. Despite this, the company has shown strong long-term share price performance, though it now trades about 16% below the average analyst price target. Its fair value is estimated at", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-as-russell-index-removal-tests-a-narrative-of-un", "source_name": "Simply Wall Street", "published_at": "2026-07-10T08:09:20", "published_display": "10 Jul 2026 08:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Axogen (AXGN)'s Russell Index Removal Means For Shareholders", "summary": "Axogen, Inc. (AXGN) was removed from several Russell indexes in late June 2026, which could impact its shareholder base and trading liquidity, though it doesn't materially change near-term fundamentals. The company's investment case hinges on the post-approval ramp of its Avance ", "url": "https://www.sahmcapital.com/news/content/what-axogen-axgns-russell-index-removal-means-for-shareholders-2026-07-06", "source_name": "Sahm", "published_at": "2026-07-06T17:22:00", "published_display": "06 Jul 2026 17:22", "sentiment": "negative", "sentiment_pct": 40, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) Left Russell Indices, Is The Upside Already Priced In?", "summary": "Axogen (AXGN) has been removed from several Russell indices, causing a 4.7% share price decline, although it still boasts significant year-to-date and 1-year returns. Conflicting valuation narratives exist, with one model suggesting it's 13.3% undervalued at $50.78 due to strong ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-left-russell-indices-is-the-upside-already-price", "source_name": "Simply Wall Street", "published_at": "2026-07-02T09:40:40", "published_display": "02 Jul 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Axogen\u2019s (AXGN) Russell Index Removal Reshape Its Liquidity Profile and Risk\u2011Reward Narrative?", "summary": "Axogen Inc. (AXGN) was recently removed from several Russell indexes, which could impact its trading liquidity and passive ownership. Despite this, the company's investment narrative remains focused on its nerve repair portfolio and achieving profitability, with 2026 revenue guid", "url": "https://www.sahmcapital.com/news/content/will-axogens-axgn-russell-index-removal-reshape-its-liquidity-profile-and-riskreward-narrative-2026-06-29", "source_name": "Sahm", "published_at": "2026-06-30T22:11:20", "published_display": "30 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen stock hits 52-week high at 46.05 USD By Investing.com", "summary": "Axogen Inc. (AXGN) stock reached a new 52-week high of $46.05, representing a 317.97% increase over the past year and a market capitalization of $2.43 billion. This surge is supported by strong revenue growth and a high gross profit margin, reflecting positive investor confidence", "url": "https://ng.investing.com/news/stock-market-news/axogen-stock-hits-52week-high-at-4605-usd-93CH-2580760", "source_name": "Investing.com Nigeria", "published_at": "2026-06-30T20:56:00", "published_display": "30 Jun 2026 20:56", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen stock hits 52-week high at 46.05 USD", "summary": "Axogen Inc. (AXGN) stock reached a new 52-week high of $46.05, representing a significant 317.97% increase over the past year and pushing its market capitalization to $2.43 billion. This surge is driven by strong revenue growth of 22% and a 75% gross profit margin. Despite its st", "url": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-4605-usd-93CH-4768611", "source_name": "Investing.com", "published_at": "2026-06-30T20:14:19", "published_display": "30 Jun 2026 20:14", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index", "summary": "Axogen, Inc. (NasdaqCM:AXGN) has been dropped from the Russell 3000E Index, the Russell Microcap Index, and the Russell 3000E Growth Benchmark. This news, published on June 29, 2026, reflects changes in the composition of these major stock market indices. The company's stock expe", "url": "https://www.marketscreener.com/news/axogen-inc-nasdaqcm-axgn-dropped-from-russell-3000e-index-ce7f5fdeda8bfe24", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:28:00", "published_display": "29 Jun 2026 12:28", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Axogen, Inc. \u2013 NASDAQ:AXGN", "summary": "This article provides financial information for Axogen, Inc. (NASDAQ: AXGN), specifically its forward price-to-earnings ratio. It is presented in a data-driven format from TradingView, focusing on key financial metrics for investors. The content is sparse, indicating the user wou", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T09:41:30", "published_display": "28 Jun 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K", "summary": "Axogen, Inc. director Alan M. Levine was granted 4,392 restricted stock units (RSUs) as an annual equity award for his service on the Board. The grant is valued at $185,000 and the RSUs are set to vest on June 24, 2027, which is the one-year anniversary of the grant date. Followi", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-0d2fc801e7ef.html", "source_name": "Stock Titan", "published_at": "2026-06-27T07:40:31", "published_display": "27 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director Paul Thomas receives $235K RSU grant vesting in 2027", "summary": "Axogen, Inc. director Paul Thomas has been granted 5,579 restricted stock units (RSUs) valued at $235,000 as equity compensation for his Board service. These RSUs will vest on June 24, 2027, which marks the one-year anniversary of the grant date. Following this transaction, Thoma", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-3a8761e8a9d3.html", "source_name": "Stock Titan", "published_at": "2026-06-27T07:40:31", "published_display": "27 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AXGN News | AXOGEN INC (NASDAQ:AXGN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE43aTBjNjRZT3dFaTV3VXdUZXVoQUFtTjVwbEo3b05VRTAyRE9NN0RFdm42R3lNLWtuXzNHNWpTSXVleTU1OUNjSHdZeHpUWGFKU2RpeXlzUHJINGM?oc=5", "source_name": "ChartMill", "published_at": "2026-06-27T00:00:02+00:00", "published_display": "27 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Axogen Inc For: 26 June By Investing.com", "summary": "The article \"Form 4 Axogen Inc For: 26 June\" from Investing.com reports on a Form 4 filing for Axogen Inc (AXGN) dated June 26, 2026. This type of filing is typically used to disclose changes in beneficial ownership of securities by company insiders. The article notes a +4.25% ch", "url": "https://ng.investing.com/news/stock-market-news/form-4-axogen-inc-for-26-june-93CH-2576557", "source_name": "Investing.com Nigeria", "published_at": "2026-06-26T21:39:23", "published_display": "26 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant", "summary": "Axogen, Inc. director Joseph A. Tyndall received an equity grant of 4,392 restricted stock units (RSUs) as compensation for his board service. This grant is valued at $185,000 and will vest on June 24, 2027, which is the one-year anniversary of the grant date. Following this awar", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-4c1857505ec6.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:04", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant", "summary": "Axogen, Inc. director William P. Burke received an annual equity grant of 4,392 restricted stock units (RSUs) as compensation for his service on the Board of Directors. These RSUs, valued at $185,000 as of the grant date, represent a contingent right to receive one share of Axoge", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-4e7b7da46fff.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director receives $185K equity grant of 4,392 RSUs vesting 2027", "summary": "Axogen, Inc. director Kathy Johnson Weiler was granted 4,392 restricted stock units (RSUs) as part of her annual equity compensation, valued at $185,000. These RSUs represent a contingent right to receive one share of Axogen common stock per unit and are set to vest on June 24, 2", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-b4b03a635cf5.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director John Johnson receives 4,392 RSUs valued at $185,000", "summary": "Axogen, Inc. director John Johnson received an annual equity grant of 4,392 restricted stock units (RSUs) as compensation for his service on the Board of Directors. This award, valued at $185,000, is scheduled to vest on June 24, 2027, provided service conditions are met. Each RS", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-0e13f4bfbf6e.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000", "summary": "Axogen (AXGN) director Wendell Amy McBride was granted 4,392 Restricted Stock Units (RSUs) as an annual equity award for her service on the Board of Directors. The grant, valued at $185,000, represents a contingent right to receive one share of common stock per unit, vesting on J", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-d0676c0d8f72.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 2025 AxoGen Inc Earnings Call Transcript", "summary": "This article provides the Q1 2025 earnings call transcript for AxoGen Inc (AXGN), detailing positive outcomes such as a 17.4% revenue increase and progress on a biologics license application (BLA) for advanced nerve graft. However, it also highlights negative aspects including a ", "url": "https://www.gurufocus.com/stock/FRA:LT3/transcripts/2847154", "source_name": "GuruFocus", "published_at": "2026-06-26T12:41:03", "published_display": "26 Jun 2026 12:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AXGN Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Axogen, Inc. (AXGN) stock, including price targets and analyst ratings for 2027. It details financial information, historical price performance, and upcoming earnings dates, alongside frequently asked questions about the company's stock, marke", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T08:10:10", "published_display": "26 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Axogen, Inc. \u2013 FWB:LT3", "summary": "This article focuses on the \"Price to earnings forward\" metric for Axogen, Inc. (FWB:LT3). The content provided is minimal, only stating the period, value, and change for this financial metric, alongside a note that it was \"Made by humans.\"", "url": "https://www.tradingview.com/symbols/FWB-LT3/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:39:46", "published_display": "25 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Actuals & Estimates (NASDAQ:AXGN)", "summary": "This article provides an in-depth financial overview of Axogen, Inc. (NASDAQ:AXGN), including its current stock price, historical performance, analyst forecasts, and various financial metrics. It details income statement, balance sheet, and cash flow data, alongside frequently as", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T18:40:05", "published_display": "25 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Axogen, Inc. \u2013 NASDAQ:AXGN", "summary": "This article focuses on the enterprise value to revenue forward metric for Axogen, Inc. (NASDAQ: AXGN). It appears to be a financial data point provided by TradingView, indicating a key valuation ratio for the company. The content itself is an extremely sparse snippet, likely a t", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T14:39:46", "published_display": "25 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) Stock After 314% One-Year Surge Is The Rally Losing Steam?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) investors approve directors, auditor and executive pay at 2026 meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQZnpZN2drczdSNHZ6bC1jdXEyQVAtdWVFaXhBaTVkRDE5STU0LXo4YWxoc2xScXVzMGFCWkVWbUpOc3FHMDlCN2dteGFNcmNBLTZjbUlFNmN6bXJSbFdST0htOWxfbHMwQXp5Rm1td0d5OVZNOEpkc2lhNGczdnQ3WGU4SkJkREFXOWRYSEZmRzhrc1lhVTlZa0pCbjJiZkZZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Axogen, Stock Of The Day, Offers Entry After Bullish Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOWGNZbEtqY0JtTk9ZTjBfVkxxeDNFX09HaVN4V0YzcW1TSUJHdml4TFB4MHo0LVh0bGNlRGcwc2FhdFMxUHRNdUZiejY0UDMtbTlZUml5TVFOc3lhV1BERDg4Y2tWWmJpdE03dUdlVGlZanhkamFsZ3BwWWVfMkRzRzdZTmNHMW83RDdSTDNRQ1lHNmJYV2lmeU14TjIxMXo4ZGc?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam", "summary": "", "url": "https://finance.yahoo.com/m/1ecb5e09-c9a4-389f-a6aa-d6276d5c9bc4/axogen-says-nerve-repair.html", "source_name": "MarketBeat", "published_at": "2026-05-14T15:06:59+00:00", "published_display": "14 May 2026 15:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/axogen-inc-participate-2026-bank-110000258.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T11:00:00+00:00", "published_display": "30 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNT2VuS0hhcWJzM2pmR3BOcWplZm9wMjZMVjkwXzRWdDM4ZFRPVm0yT21KYWtpWVVZZXVhNXpzVExYNTVQbVJvQlV6cXh2MzNoT3N4VzhwcU5PNVZNUnpSVldOVHNKdTVoMGtib1VFU0d1QjRIWE1WZGtzM2QyV2RiRXlQMUxrZVNSVTZVNWpndXNNdkx2aHhzOURvbUI?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen executives take Bank of America healthcare stage May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPelVQcjdCaHkzZnVzLUtINkNqdWQyODNheF80ZFZGcHRLc0hKaXpWRXhJZm05OEZFM1N2ZTFFYXNWTmFuZzF3aFRzbjZVZERDemR3VWpLaUpZWVB2anNhdXhNRzBXNEJ4aXJ1VDE2dlgzOThpQXUxWnF0R1U4Y0xlV2d0M0wzT21XLUFmd01LcGdqd2R5Nlh0V1otaUlVU084UkV4UFZ4ZFNVWUptYmR5NVBMSWIwZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/axogen-inc-axgn-q1-2026-070323534.html", "source_name": "GuruFocus.com", "published_at": "2026-04-29T07:03:23+00:00", "published_display": "29 Apr 2026 07:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AXOGEN ($AXGN) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNU2l5U3Z2cTRWaGRCOHpNdXJoSHNIR0RkRTlKTExja3MwNHdRY2dIc2lmMGVXR3FUM1UwNTNveU1nekR0d2hQbTRIOE0zU3JjODFPYlQ3eXVYOXlhWkdTY195c09oRzJOR2xiZjV1NWZNSmhSMnlVeGtCN0pad0Q4cTBkbDBoUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQeE0tYlpVejNSV3ZPUlBJWG1FM3R1ZzBDZlZYOXBvaUY2bm1HYlhMeFdJa2lmTFZiX0N2dUNWWkFXdGl3ZDN0eFJzX0FYcVMtWklKZ3A0S3duOGRwanE5enMtUEFNaHhaTV9XdHQ0RXdGRUxsb2ZlbWExem11SXBTTTBkUHRJQkpIWEFtWjBHbGM3T3Z6RWVXcFBYUi13TVNSRUk1UGZNdmR3SU1maTZBX0NaYnNXeUxUUW9CMDZsVzd1TlZ4QVE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQekJtMWY3ek1iME9mbFVFNkgyTjBudXFiMTgzYmx0MC15a0dxM0pNZU1DaVYyUGdzNjh2Q2tLa2h3c0QxNGNvNnM5cEc3SGlaU2FOcVNhbm1Sck01OFc4SGY5VXNkM04wUEE2WDNFTGRlNHNId1hLMFVLRkk2ajMzU1V2ZUlKdFU0QjVaN2dNMFBrb0ZfNWRLVTJiYVdDcGo3eHBOLVBlYkF1ZHd0Q2ItRXZ1Y0ZVQmxCQUtfbjZzVmE1U20ybE5ST05Cb1doZmVrSDNTbDNIc2Z4NzZ3bUVWV1kzZXpLOFVkVlQ3M2VTTFQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Axogen (AXGN) After Its 1\u2011Year Share Price Surge?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMUhOLTVOcnEzUUtCeDdjNmRfZ3lGRU42Vkx0eXhlV01JWjJZNXM0TmtvTS1odzZ6UEdvZ1FqTE9NUHRwZkFZaVNSUDEwVGlkaU5NVDJsV2ZYZUdHWnoydy1ZbjFvOWI5SUk5Y3NxaDdyZFFGa3Z6LWhUakhMak0tTF9sRTZ1MU5GRWUtbUxicmtzNUEyMFE?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNNllic3ZGbVVyTTQ5Q1llVkVQeGxzSGRBeW0tT3JuaFNaWnJuZWxyb2U0SzhpN3pFUjBna3YweEVMUFpETHUxZTFBR2huT2pWdnhYeXdRd29KZWc5S3lkOU53amhoZVlpb3pwN3F5MGdLc19kcENaWDktWTRGa25IUnRLVkdmeU1WbEtNWXF1WXM?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Axogen (AXGN) Valuation After Strong Recent Share Price Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOWkxPODA0Yy1iMmxQaWxDYjcyVms4WXlaTWEwZFVYc3RRRVRnMExvT3JzQWNLWTJ1WEppVVk2eEdpblZFcmQ5dDA4S3RFdWNaWDI0akhpR1d2RjlMS2l1cC1MNUJZeHFnNEpFMHdvaE1oOTA2cVdtdkVhd2d6bFdsLUtfYnNvd3A0VXo5VXQ3bjN0X3F2OEVVWGdMMWE2T0RhQkExZXpn?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "What Makes Axogen (AXGN) an Investment Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNZC14MFQtLUxSZTlFUTJzNnpiODRlZFlES045Zml0cnNEMzNoQndUOTNlTE5hSF9xRTY3YWM0NFRTdUxyaU5NQ1QtcEVpamFSQ24yOC1SLVJHOC0wUjhEZmZSdWVLbWV2cTRiWFBxQUJJc0dONDVYT09VcS1KRF9rTlFhLXpNTGFHR082U3JjVUxWbl9Pb2I5dTVXOFhQdw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Axogen, Inc. Rings the Nasdaq Stock Market Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQkVzaEcxS1BPQzJtYnJRV1k5dUdtaEZxUzJfQWE2UE8xNHc5MEo0alcwQXVnNnN1T3hnVUVfVEl0SHIxVURtc1BsNWVwTkJZc00zQlY1bVpkaDBlUVd6OEw0dUZUWUxZOVdQMXdjT0trZS1Kb1Z2MDUzWEpLdmJmZUVRYVoxUQ?oc=5", "source_name": "Nasdaq", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQMUo3cTlhRDdhUS1zMjdrVHA5ZUFPOXJ0bmNBTlRjYVdaUVpKcU5TLUI5eWxfVXRXaXdJUU11TGR2RWFHRTR1QzhETjlvQXpncXpzV0JWeTl5clNSX3hydER1aHJmV0ZCaXZaLWRPeUdZY2NRX2hNZ2wxOWtqNWtZUk9WR2hGMzFILXQ1N2FRT1BTREFWbFA0OXpZLWtCVDVnc3FRWkVCd0d1Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. (AXGN) Stock Price Today: $40.58", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5Jc01BbTJPd3BwN05YNElUQVNJb2FhTVFhVkxla1l1SXhsU2tHYUl0X1VzUmZPZ2UzODRfclpvbEtSYVRfNDg1VUJ6MDg0X251Z1Z5LXRUOA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-09T21:27:56+00:00", "published_display": "09 Jan 2026 21:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Receives FDA Extension for Avance\u00ae Nerve Graft Biologics License Application Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVFdRNHVaeHdzZlRIMlo0YlBGcW5BZnlMQjA5VmJHalh3VE9JUjh5WjZiNUUtcWhnMWh1MGFCQUF3ZTBNaVZ0SXJubkFILUMzM19PSWFxbUllSmkzc25tUjlUMWxTbU4zZ3lBcWFEMVgzVjFiUUVFbDdUTUJBUnJrcGM1ZWlNX1VhOC1UNndpT0kwdkw5N2tHLTBaOWpFTGpLaTc4dThnZFh1OG5YQklsdVRLZHMtakp6RWN4Ul82ckNuTzZiSWQ3V0NUSkV5Rm05THc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AxoGen (AXGN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBORjFkaTVPWFcwSTBCdFFINmFjTTlGaDhMTEdjNkUtQnZURHpmUDNwTzNpTWJkdkxpbWV5aFBFUEc0QUVwalNtSXVudHA2Wi1vZ2hwTV9zUE53Zw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T06:56:43+00:00", "published_display": "12 Aug 2016 06:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "(AXGN) and the Role of Price-Sensitive Allocations", "summary": "Axogen Inc. (NASDAQ: AXGN) is showing weak near and mid-term sentiment, but a strong long", "url": "https://news.stocktradersdaily.com/news_release/24/AXGN_and_the_Role_of_Price-Sensitive_Allocations_071726075002_1784289002.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-17T07:39:43", "published_display": "17 Jul 2026 07:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026", "summary": "Axogen, Inc. announced that it will release its second quarter 2026 financial results on Wednesday, July 29, 2026. Following the release, Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET. The company specializes in surgical solutions", "url": "https://sg.finance.yahoo.com/news/axogen-inc-report-second-quarter-110000045.html", "source_name": "Market source", "published_at": "2026-07-15T14:39:43", "published_display": "15 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen schedules investor webcast after July 29 results", "summary": "Axogen (Nasdaq: AXGN) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, followed by a conference call and webcast hosted by management at 8:00 a.m. ET. Investors can access the call via phone or webcast on the Axogen Investors webpag", "url": "https://www.stocktitan.net/news/AXGN/axogen-inc-to-report-second-quarter-2026-financial-results-on-july-lfanadem2e9o.html", "source_name": "Stock Titan", "published_at": "2026-07-15T10:45:07", "published_display": "15 Jul 2026 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) As Russell Index Removal Tests A Narrative Of Undervaluation", "summary": "Axogen (AXGN) has been removed from several Russell indexes, potentially reshaping trading patterns. Despite this, the company has shown strong long-term share price performance, though it now trades about 16% below the average analyst price target. Its fair value is estimated at", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-as-russell-index-removal-tests-a-narrative-of-un", "source_name": "Simply Wall Street", "published_at": "2026-07-10T08:09:20", "published_display": "10 Jul 2026 08:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Axogen (AXGN)'s Russell Index Removal Means For Shareholders", "summary": "Axogen, Inc. (AXGN) was removed from several Russell indexes in late June 2026, which could impact its shareholder base and trading liquidity, though it doesn't materially change near-term fundamentals. The company's investment case hinges on the post-approval ramp of its Avance ", "url": "https://www.sahmcapital.com/news/content/what-axogen-axgns-russell-index-removal-means-for-shareholders-2026-07-06", "source_name": "Sahm", "published_at": "2026-07-06T17:22:00", "published_display": "06 Jul 2026 17:22", "sentiment": "negative", "sentiment_pct": 40, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) Left Russell Indices, Is The Upside Already Priced In?", "summary": "Axogen (AXGN) has been removed from several Russell indices, causing a 4.7% share price decline, although it still boasts significant year-to-date and 1-year returns. Conflicting valuation narratives exist, with one model suggesting it's 13.3% undervalued at $50.78 due to strong ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-left-russell-indices-is-the-upside-already-price", "source_name": "Simply Wall Street", "published_at": "2026-07-02T09:40:40", "published_display": "02 Jul 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Axogen\u2019s (AXGN) Russell Index Removal Reshape Its Liquidity Profile and Risk\u2011Reward Narrative?", "summary": "Axogen Inc. (AXGN) was recently removed from several Russell indexes, which could impact its trading liquidity and passive ownership. Despite this, the company's investment narrative remains focused on its nerve repair portfolio and achieving profitability, with 2026 revenue guid", "url": "https://www.sahmcapital.com/news/content/will-axogens-axgn-russell-index-removal-reshape-its-liquidity-profile-and-riskreward-narrative-2026-06-29", "source_name": "Sahm", "published_at": "2026-06-30T22:11:20", "published_display": "30 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen stock hits 52-week high at 46.05 USD By Investing.com", "summary": "Axogen Inc. (AXGN) stock reached a new 52-week high of $46.05, representing a 317.97% increase over the past year and a market capitalization of $2.43 billion. This surge is supported by strong revenue growth and a high gross profit margin, reflecting positive investor confidence", "url": "https://ng.investing.com/news/stock-market-news/axogen-stock-hits-52week-high-at-4605-usd-93CH-2580760", "source_name": "Investing.com Nigeria", "published_at": "2026-06-30T20:56:00", "published_display": "30 Jun 2026 20:56", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen stock hits 52-week high at 46.05 USD", "summary": "Axogen Inc. (AXGN) stock reached a new 52-week high of $46.05, representing a significant 317.97% increase over the past year and pushing its market capitalization to $2.43 billion. This surge is driven by strong revenue growth of 22% and a 75% gross profit margin. Despite its st", "url": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-4605-usd-93CH-4768611", "source_name": "Investing.com", "published_at": "2026-06-30T20:14:19", "published_display": "30 Jun 2026 20:14", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index", "summary": "Axogen, Inc. (NasdaqCM:AXGN) has been dropped from the Russell 3000E Index, the Russell Microcap Index, and the Russell 3000E Growth Benchmark. This news, published on June 29, 2026, reflects changes in the composition of these major stock market indices. The company's stock expe", "url": "https://www.marketscreener.com/news/axogen-inc-nasdaqcm-axgn-dropped-from-russell-3000e-index-ce7f5fdeda8bfe24", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:28:00", "published_display": "29 Jun 2026 12:28", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Axogen, Inc. \u2013 NASDAQ:AXGN", "summary": "This article provides financial information for Axogen, Inc. (NASDAQ: AXGN), specifically its forward price-to-earnings ratio. It is presented in a data-driven format from TradingView, focusing on key financial metrics for investors. The content is sparse, indicating the user wou", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T09:41:30", "published_display": "28 Jun 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K", "summary": "Axogen, Inc. director Alan M. Levine was granted 4,392 restricted stock units (RSUs) as an annual equity award for his service on the Board. The grant is valued at $185,000 and the RSUs are set to vest on June 24, 2027, which is the one-year anniversary of the grant date. Followi", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-0d2fc801e7ef.html", "source_name": "Stock Titan", "published_at": "2026-06-27T07:40:31", "published_display": "27 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director Paul Thomas receives $235K RSU grant vesting in 2027", "summary": "Axogen, Inc. director Paul Thomas has been granted 5,579 restricted stock units (RSUs) valued at $235,000 as equity compensation for his Board service. These RSUs will vest on June 24, 2027, which marks the one-year anniversary of the grant date. Following this transaction, Thoma", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-3a8761e8a9d3.html", "source_name": "Stock Titan", "published_at": "2026-06-27T07:40:31", "published_display": "27 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AXGN News | AXOGEN INC (NASDAQ:AXGN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE43aTBjNjRZT3dFaTV3VXdUZXVoQUFtTjVwbEo3b05VRTAyRE9NN0RFdm42R3lNLWtuXzNHNWpTSXVleTU1OUNjSHdZeHpUWGFKU2RpeXlzUHJINGM?oc=5", "source_name": "ChartMill", "published_at": "2026-06-27T00:00:02+00:00", "published_display": "27 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Axogen Inc For: 26 June By Investing.com", "summary": "The article \"Form 4 Axogen Inc For: 26 June\" from Investing.com reports on a Form 4 filing for Axogen Inc (AXGN) dated June 26, 2026. This type of filing is typically used to disclose changes in beneficial ownership of securities by company insiders. The article notes a +4.25% ch", "url": "https://ng.investing.com/news/stock-market-news/form-4-axogen-inc-for-26-june-93CH-2576557", "source_name": "Investing.com Nigeria", "published_at": "2026-06-26T21:39:23", "published_display": "26 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant", "summary": "Axogen, Inc. director Joseph A. Tyndall received an equity grant of 4,392 restricted stock units (RSUs) as compensation for his board service. This grant is valued at $185,000 and will vest on June 24, 2027, which is the one-year anniversary of the grant date. Following this awar", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-4c1857505ec6.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:04", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant", "summary": "Axogen, Inc. director William P. Burke received an annual equity grant of 4,392 restricted stock units (RSUs) as compensation for his service on the Board of Directors. These RSUs, valued at $185,000 as of the grant date, represent a contingent right to receive one share of Axoge", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-4e7b7da46fff.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director receives $185K equity grant of 4,392 RSUs vesting 2027", "summary": "Axogen, Inc. director Kathy Johnson Weiler was granted 4,392 restricted stock units (RSUs) as part of her annual equity compensation, valued at $185,000. These RSUs represent a contingent right to receive one share of Axogen common stock per unit and are set to vest on June 24, 2", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-b4b03a635cf5.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director John Johnson receives 4,392 RSUs valued at $185,000", "summary": "Axogen, Inc. director John Johnson received an annual equity grant of 4,392 restricted stock units (RSUs) as compensation for his service on the Board of Directors. This award, valued at $185,000, is scheduled to vest on June 24, 2027, provided service conditions are met. Each RS", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-0e13f4bfbf6e.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000", "summary": "Axogen (AXGN) director Wendell Amy McBride was granted 4,392 Restricted Stock Units (RSUs) as an annual equity award for her service on the Board of Directors. The grant, valued at $185,000, represents a contingent right to receive one share of common stock per unit, vesting on J", "url": "https://www.stocktitan.net/sec-filings/AXGN/form-4-axogen-inc-insider-trading-activity-d0676c0d8f72.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:03", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 2025 AxoGen Inc Earnings Call Transcript", "summary": "This article provides the Q1 2025 earnings call transcript for AxoGen Inc (AXGN), detailing positive outcomes such as a 17.4% revenue increase and progress on a biologics license application (BLA) for advanced nerve graft. However, it also highlights negative aspects including a ", "url": "https://www.gurufocus.com/stock/FRA:LT3/transcripts/2847154", "source_name": "GuruFocus", "published_at": "2026-06-26T12:41:03", "published_display": "26 Jun 2026 12:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AXGN Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Axogen, Inc. (AXGN) stock, including price targets and analyst ratings for 2027. It details financial information, historical price performance, and upcoming earnings dates, alongside frequently asked questions about the company's stock, marke", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T08:10:10", "published_display": "26 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Axogen, Inc. \u2013 FWB:LT3", "summary": "This article focuses on the \"Price to earnings forward\" metric for Axogen, Inc. (FWB:LT3). The content provided is minimal, only stating the period, value, and change for this financial metric, alongside a note that it was \"Made by humans.\"", "url": "https://www.tradingview.com/symbols/FWB-LT3/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:39:46", "published_display": "25 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Actuals & Estimates (NASDAQ:AXGN)", "summary": "This article provides an in-depth financial overview of Axogen, Inc. (NASDAQ:AXGN), including its current stock price, historical performance, analyst forecasts, and various financial metrics. It details income statement, balance sheet, and cash flow data, alongside frequently as", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T18:40:05", "published_display": "25 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Axogen, Inc. \u2013 NASDAQ:AXGN", "summary": "This article focuses on the enterprise value to revenue forward metric for Axogen, Inc. (NASDAQ: AXGN). It appears to be a financial data point provided by TradingView, indicating a key valuation ratio for the company. The content itself is an extremely sparse snippet, likely a t", "url": "https://www.tradingview.com/symbols/NASDAQ-AXGN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T14:39:46", "published_display": "25 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) Stock After 314% One-Year Surge Is The Rally Losing Steam?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen (AXGN) investors approve directors, auditor and executive pay at 2026 meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQZnpZN2drczdSNHZ6bC1jdXEyQVAtdWVFaXhBaTVkRDE5STU0LXo4YWxoc2xScXVzMGFCWkVWbUpOc3FHMDlCN2dteGFNcmNBLTZjbUlFNmN6bXJSbFdST0htOWxfbHMwQXp5Rm1td0d5OVZNOEpkc2lhNGczdnQ3WGU4SkJkREFXOWRYSEZmRzhrc1lhVTlZa0pCbjJiZkZZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Stock Of The Day, Offers Entry After Bullish Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOWGNZbEtqY0JtTk9ZTjBfVkxxeDNFX09HaVN4V0YzcW1TSUJHdml4TFB4MHo0LVh0bGNlRGcwc2FhdFMxUHRNdUZiejY0UDMtbTlZUml5TVFOc3lhV1BERDg4Y2tWWmJpdE03dUdlVGlZanhkamFsZ3BwWWVfMkRzRzdZTmNHMW83RDdSTDNRQ1lHNmJYV2lmeU14TjIxMXo4ZGc?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam", "summary": "", "url": "https://finance.yahoo.com/m/1ecb5e09-c9a4-389f-a6aa-d6276d5c9bc4/axogen-says-nerve-repair.html", "source_name": "MarketBeat", "published_at": "2026-05-14T15:06:59+00:00", "published_display": "14 May 2026 15:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/axogen-inc-participate-2026-bank-110000258.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T11:00:00+00:00", "published_display": "30 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNT2VuS0hhcWJzM2pmR3BOcWplZm9wMjZMVjkwXzRWdDM4ZFRPVm0yT21KYWtpWVVZZXVhNXpzVExYNTVQbVJvQlV6cXh2MzNoT3N4VzhwcU5PNVZNUnpSVldOVHNKdTVoMGtib1VFU0d1QjRIWE1WZGtzM2QyV2RiRXlQMUxrZVNSVTZVNWpndXNNdkx2aHhzOURvbUI?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen executives take Bank of America healthcare stage May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPelVQcjdCaHkzZnVzLUtINkNqdWQyODNheF80ZFZGcHRLc0hKaXpWRXhJZm05OEZFM1N2ZTFFYXNWTmFuZzF3aFRzbjZVZERDemR3VWpLaUpZWVB2anNhdXhNRzBXNEJ4aXJ1VDE2dlgzOThpQXUxWnF0R1U4Y0xlV2d0M0wzT21XLUFmd01LcGdqd2R5Nlh0V1otaUlVU084UkV4UFZ4ZFNVWUptYmR5NVBMSWIwZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/axogen-inc-axgn-q1-2026-070323534.html", "source_name": "GuruFocus.com", "published_at": "2026-04-29T07:03:23+00:00", "published_display": "29 Apr 2026 07:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AXOGEN ($AXGN) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNU2l5U3Z2cTRWaGRCOHpNdXJoSHNIR0RkRTlKTExja3MwNHdRY2dIc2lmMGVXR3FUM1UwNTNveU1nekR0d2hQbTRIOE0zU3JjODFPYlQ3eXVYOXlhWkdTY195c09oRzJOR2xiZjV1NWZNSmhSMnlVeGtCN0pad0Q4cTBkbDBoUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQeE0tYlpVejNSV3ZPUlBJWG1FM3R1ZzBDZlZYOXBvaUY2bm1HYlhMeFdJa2lmTFZiX0N2dUNWWkFXdGl3ZDN0eFJzX0FYcVMtWklKZ3A0S3duOGRwanE5enMtUEFNaHhaTV9XdHQ0RXdGRUxsb2ZlbWExem11SXBTTTBkUHRJQkpIWEFtWjBHbGM3T3Z6RWVXcFBYUi13TVNSRUk1UGZNdmR3SU1maTZBX0NaYnNXeUxUUW9CMDZsVzd1TlZ4QVE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQekJtMWY3ek1iME9mbFVFNkgyTjBudXFiMTgzYmx0MC15a0dxM0pNZU1DaVYyUGdzNjh2Q2tLa2h3c0QxNGNvNnM5cEc3SGlaU2FOcVNhbm1Sck01OFc4SGY5VXNkM04wUEE2WDNFTGRlNHNId1hLMFVLRkk2ajMzU1V2ZUlKdFU0QjVaN2dNMFBrb0ZfNWRLVTJiYVdDcGo3eHBOLVBlYkF1ZHd0Q2ItRXZ1Y0ZVQmxCQUtfbjZzVmE1U20ybE5ST05Cb1doZmVrSDNTbDNIc2Z4NzZ3bUVWV1kzZXpLOFVkVlQ3M2VTTFQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Axogen (AXGN) After Its 1\u2011Year Share Price Surge?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMUhOLTVOcnEzUUtCeDdjNmRfZ3lGRU42Vkx0eXhlV01JWjJZNXM0TmtvTS1odzZ6UEdvZ1FqTE9NUHRwZkFZaVNSUDEwVGlkaU5NVDJsV2ZYZUdHWnoydy1ZbjFvOWI5SUk5Y3NxaDdyZFFGa3Z6LWhUakhMak0tTF9sRTZ1MU5GRWUtbUxicmtzNUEyMFE?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNNllic3ZGbVVyTTQ5Q1llVkVQeGxzSGRBeW0tT3JuaFNaWnJuZWxyb2U0SzhpN3pFUjBna3YweEVMUFpETHUxZTFBR2huT2pWdnhYeXdRd29KZWc5S3lkOU53amhoZVlpb3pwN3F5MGdLc19kcENaWDktWTRGa25IUnRLVkdmeU1WbEtNWXF1WXM?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Axogen (AXGN) Valuation After Strong Recent Share Price Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOWkxPODA0Yy1iMmxQaWxDYjcyVms4WXlaTWEwZFVYc3RRRVRnMExvT3JzQWNLWTJ1WEppVVk2eEdpblZFcmQ5dDA4S3RFdWNaWDI0akhpR1d2RjlMS2l1cC1MNUJZeHFnNEpFMHdvaE1oOTA2cVdtdkVhd2d6bFdsLUtfYnNvd3A0VXo5VXQ3bjN0X3F2OEVVWGdMMWE2T0RhQkExZXpn?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Axogen (AXGN) an Investment Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNZC14MFQtLUxSZTlFUTJzNnpiODRlZFlES045Zml0cnNEMzNoQndUOTNlTE5hSF9xRTY3YWM0NFRTdUxyaU5NQ1QtcEVpamFSQ24yOC1SLVJHOC0wUjhEZmZSdWVLbWV2cTRiWFBxQUJJc0dONDVYT09VcS1KRF9rTlFhLXpNTGFHR082U3JjVUxWbl9Pb2I5dTVXOFhQdw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Rings the Nasdaq Stock Market Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQkVzaEcxS1BPQzJtYnJRV1k5dUdtaEZxUzJfQWE2UE8xNHc5MEo0alcwQXVnNnN1T3hnVUVfVEl0SHIxVURtc1BsNWVwTkJZc00zQlY1bVpkaDBlUVd6OEw0dUZUWUxZOVdQMXdjT0trZS1Kb1Z2MDUzWEpLdmJmZUVRYVoxUQ?oc=5", "source_name": "Nasdaq", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQMUo3cTlhRDdhUS1zMjdrVHA5ZUFPOXJ0bmNBTlRjYVdaUVpKcU5TLUI5eWxfVXRXaXdJUU11TGR2RWFHRTR1QzhETjlvQXpncXpzV0JWeTl5clNSX3hydER1aHJmV0ZCaXZaLWRPeUdZY2NRX2hNZ2wxOWtqNWtZUk9WR2hGMzFILXQ1N2FRT1BTREFWbFA0OXpZLWtCVDVnc3FRWkVCd0d1Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. (AXGN) Stock Price Today: $40.58", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5Jc01BbTJPd3BwN05YNElUQVNJb2FhTVFhVkxla1l1SXhsU2tHYUl0X1VzUmZPZ2UzODRfclpvbEtSYVRfNDg1VUJ6MDg0X251Z1Z5LXRUOA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-09T21:27:56+00:00", "published_display": "09 Jan 2026 21:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Axogen, Inc. Receives FDA Extension for Avance\u00ae Nerve Graft Biologics License Application Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVFdRNHVaeHdzZlRIMlo0YlBGcW5BZnlMQjA5VmJHalh3VE9JUjh5WjZiNUUtcWhnMWh1MGFCQUF3ZTBNaVZ0SXJubkFILUMzM19PSWFxbUllSmkzc25tUjlUMWxTbU4zZ3lBcWFEMVgzVjFiUUVFbDdUTUJBUnJrcGM1ZWlNX1VhOC1UNndpT0kwdkw5N2tHLTBaOWpFTGpLaTc4dThnZFh1OG5YQklsdVRLZHMtakp6RWN4Ul82ckNuTzZiSWQ3V0NUSkV5Rm05THc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AxoGen (AXGN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBORjFkaTVPWFcwSTBCdFFINmFjTTlGaDhMTEdjNkUtQnZURHpmUDNwTzNpTWJkdkxpbWV5aFBFUEc0QUVwalNtSXVudHA2Wi1vZ2hwTV9zUE53Zw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T06:56:43+00:00", "published_display": "12 Aug 2016 06:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 91, "total_relevant": 57, "sentiment_summary": {"positive": 12, "negative": 4, "neutral": 41, "score": 53, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 14.85, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 13.14, "count": 26}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 40.58, "latest_week": "2026-07-10", "one_week_move": -11.6, "four_week_move": -5.6, "twelve_week_move": 5.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.999624, "market_dynamics_buy_signal": false, "relative_strength": 21.308177, "fair_value_gap": 141.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 60.3068, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-11.6% over one week, -5.6% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 15}, {"label": "Stock Titan", "count": 10}, {"label": "TradingView", "count": 5}, {"label": "Simply Wall Street", "count": 2}, {"label": "Sahm", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 46}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 26}, {"label": "Analyst action", "count": 3}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "46", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-11.6% over one week, -5.6% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "(AXGN) and the Role of Price-Sensitive Allocations"}], "updated_at": "2026-07-17T21:05:49.790069+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}